Publication | Closed Access

Dose-dependent access of murine anti-epidermal growth factor receptor monoclonal antibody to tumor cells in patients with advanced laryngeal and hypopharyngeal carcinoma

Dose-dependent AccessMedicineImmunologyTumor ImmunityAdvanced LaryngealImmunoeditingHead And Neck CancerHypopharyngeal CarcinomaNeck OncologyImmunotherapyOncologyRadiation OncologyCancer ResearchCancer Growth